Additional segmental information and capital data
Additional segmental information |
$ million |
||||||||
---|---|---|---|---|---|---|---|---|---|
|
2018 |
2017 |
2016 |
2015 |
2014 |
||||
|
|||||||||
Integrated Gas |
|
|
|
|
|
||||
Segment earnings |
11,444 |
5,078 |
2,529 |
3,170 |
10,610 |
||||
Including: |
|
|
|
|
|
||||
Exploration |
208 |
141 |
494 |
1,290 |
1,439 |
||||
Depreciation, depletion and amortisation |
4,850 |
4,965 |
4,509 |
2,596 |
2,661 |
||||
Of which: impairment losses and reversals |
200 |
292 |
72 |
210 |
94 |
||||
Share of profit/(loss) of joint ventures and associates |
2,273 |
1,714 |
1,116 |
1,469 |
4,324 |
||||
Production and manufacturing expenses |
5,370 |
5,120 |
5,786 |
3,102 |
3,538 |
||||
Selling, distribution and administrative expenses |
458 |
237 |
584 |
546 |
607 |
||||
Research and development |
186 |
114 |
108 |
440 |
465 |
||||
Cash flow from operating activities |
14,617 |
6,467 |
9,132 |
7,728 |
12,689 |
||||
(Increase)/decrease in working capital [A] |
(1,664) |
(2,192) |
1,159 |
152 |
(1,232) |
||||
Cash flow from operating activities excluding working capital [A] |
16,281 |
8,659 |
7,973 |
7,576 |
13,921 |
||||
Cash flow from investing activities |
(1,513) |
(1,357) |
(8,256) |
(4,486) |
(1,998) |
||||
Free Cash Flow |
13,104 |
5,110 |
876 |
3,242 |
10,691 |
||||
Capital employed |
86,850 |
87,462 |
86,631 |
62,481 |
62,127 |
||||
Upstream |
|
|
|
|
|
||||
Segment earnings |
6,798 |
1,551 |
(3,674) |
(8,833) |
5,231 |
||||
Including: |
|
|
|
|
|
||||
Exploration |
1,132 |
1,804 |
1,614 |
4,429 |
2,785 |
||||
Depreciation, depletion and amortisation |
13,006 |
17,303 |
16,779 |
20,405 |
15,207 |
||||
Of which: impairment losses and reversals |
(200) |
3,513 |
1,274 |
8,536 |
3,394 |
||||
Share of profit/(loss) of joint ventures and associates |
285 |
623 |
222 |
493 |
1,178 |
||||
Production and manufacturing expenses |
11,463 |
12,119 |
13,396 |
14,914 |
16,555 |
||||
Selling, distribution and administrative expenses |
201 |
5 |
556 |
464 |
448 |
||||
Research and development |
493 |
532 |
549 |
361 |
390 |
||||
Cash flow from operating activities [B] |
22,661 |
16,337 |
7,662 |
5,453 |
19,150 |
||||
(Increase)/decrease in working capital [A] |
744 |
(2) |
(2,109) |
1,146 |
2,043 |
||||
Cash flow from operating activities excluding working capital [A] |
21,917 |
16,339 |
9,771 |
4,307 |
17,107 |
||||
Cash flow from investing activities [B] |
(9,261) |
(289) |
(18,876) |
(15,165) |
(14,727) |
||||
Free Cash Flow |
13,400 |
16,048 |
(11,214) |
(9,712) |
4,423 |
||||
Capital employed |
115,312 |
119,253 |
128,782 |
84,727 |
88,692 |
||||
Downstream |
|
|
|
|
|
||||
Segment CCS earnings |
7,601 |
8,258 |
6,588 |
10,243 |
3,411 |
||||
Including: |
|
|
|
|
|
||||
Depreciation, depletion and amortisation |
4,064 |
3,877 |
3,681 |
3,667 |
6,619 |
||||
Of which: impairment losses and reversals |
424 |
385 |
550 |
553 |
3,141 |
||||
Share of profit/(loss) of joint ventures and associates |
1,785 |
1,956 |
2,244 |
2,215 |
1,693 |
||||
Production and manufacturing expenses |
10,294 |
9,519 |
9,208 |
9,994 |
9,845 |
||||
Selling, distribution and administrative expenses |
10,142 |
9,789 |
10,117 |
10,531 |
12,489 |
||||
Research and development |
307 |
275 |
357 |
292 |
367 |
||||
Cash flow from operating activities |
13,928 |
12,429 |
3,556 |
14,076 |
11,292 |
||||
(Increase)/decrease in working capital [A] |
3,164 |
(148) |
(6,866) |
3,188 |
8,103 |
||||
Cash flow from operating activities excluding working capital [A] |
10,764 |
12,577 |
10,422 |
10,888 |
3,189 |
||||
Cash flow from investing activities |
(6,714) |
(3,585) |
(3,967) |
(3,304) |
(2,841) |
||||
Free Cash Flow |
7,214 |
8,844 |
(411) |
10,772 |
8,451 |
||||
Capital employed |
56,633 |
56,431 |
52,672 |
46,280 |
48,925 |
||||
Corporate |
|
|
|
|
|
||||
Segment earnings |
(1,479) |
(2,416) |
(1,751) |
(425) |
(156) |
||||
Comprising: |
|
|
|
|
|
||||
Net interest and investment income/(expense) |
(2,192) |
(2,413) |
(1,824) |
(995) |
(913) |
||||
Foreign exchange (losses)/gains |
(67) |
(292) |
3 |
(731) |
(263) |
||||
Taxation and other |
780 |
289 |
70 |
1,301 |
1,020 |
||||
Cash flow from operating activities |
1,879 |
417 |
265 |
2,553 |
1,913 |
||||
(Increase)/decrease in working capital [A] |
1,198 |
92 |
(610) |
249 |
(132) |
||||
Cash flow from operating activities excluding working capital [A] |
681 |
325 |
875 |
2,304 |
2,045 |
||||
Cash flow from investing activities |
3,829 |
(2,798) |
136 |
549 |
(90) |
||||
Free Cash Flow |
5,708 |
(2,381) |
401 |
3,102 |
1,823 |
||||
Capital employed |
20,563 |
20,331 |
12,903 |
29,012 |
18,582 |
||||
Royal Dutch Shell |
|
|
|
|
|
||||
CCS earnings |
24,364 |
12,471 |
3,692 |
4,155 |
19,096 |
||||
Less: Non-controlling interest |
(531) |
(390) |
(159) |
(313) |
(55) |
||||
CCS earnings attributable to shareholders |
23,833 |
12,081 |
3,533 |
3,842 |
19,041 |
||||
Cash flow from operating activities |
53,085 |
35,650 |
20,615 |
29,810 |
45,044 |
||||
(Increase)/decrease in working capital [A] |
3,442 |
(2,250) |
(8,426) |
4,735 |
8,782 |
||||
Cash flow from operating activities excluding working capital [A] |
49,643 |
37,900 |
29,041 |
25,075 |
36,262 |
||||
Cash flow from investing activities |
(13,659) |
(8,029) |
(30,963) |
(22,406) |
(19,656) |
||||
Free Cash Flow |
39,426 |
27,621 |
(10,348) |
7,404 |
25,388 |
||||
Capital employed |
279,358 |
283,477 |
280,988 |
222,500 |
218,326 |
Operating expenses |
$ million |
||||
---|---|---|---|---|---|
|
2018 |
2017 |
2016 |
2015 |
2014 |
Production and manufacturing expenses |
26,970 |
26,652 |
28,434 |
28,095 |
30,038 |
Selling, distribution and administrative expenses |
11,360 |
10,509 |
12,101 |
11,956 |
13,965 |
Research and development |
986 |
922 |
1,014 |
1,093 |
1,222 |
Operating expenses |
39,316 |
38,083 |
41,549 |
41,144 |
45,225 |
Less identified items: |
|
|
|
|
|
Redundancy and restructuring charges |
(187) |
(565) |
(1,870) |
(430) |
(606) |
Provisions |
(104) |
38 |
(915) |
(1,150) |
(460) |
BG acquisition costs |
– |
– |
(422) |
– |
– |
Pension plan amendment |
– |
– |
– |
– |
1,033 |
|
(291) |
(527) |
(3,207) |
(1,580) |
(33) |
Underlying operating expenses |
39,025 |
37,556 |
38,342 |
39,564 |
45,192 |
Operating expenses is a measure of Shell's total operating expenses performance, comprising the following items from the Consolidated Statement of Income: production and manufacturing expenses; selling, distribution and administrative expenses; and research and development expenses. Underlying operating expenses measures Shell's total operating expenses performance excluding identified items. Underlying operating expenses is a non-GAAP measure (see definition of identified items in the "Quarterly data per segment" section).
Divestments |
$ million |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2018 |
2017 |
2016 |
2015 |
2014 |
||||||||
|
|||||||||||||
Proceeds from sale of property, plant and equipment and businesses [A] |
4,366 |
8,808 |
2,072 |
4,720 |
9,873 |
||||||||
Proceeds from sale of joint ventures and associates [A] |
1,594 |
2,177 |
1,565 |
276 |
4,163 |
||||||||
Share and contingent consideration [B] |
194 |
3,046 |
275 |
– |
– |
||||||||
Proceeds from sale of interests in entities while retaining control [C] |
673 |
278 |
1,108 |
595 |
1,012 |
||||||||
Other |
275 |
3,031[D] |
(36) |
(51) |
(29) |
||||||||
Total |
7,102 |
17,340 |
4,984 |
5,540 |
15,019 |
||||||||
Integrated Gas |
3,124 |
3,077 |
352 |
269 |
4,819 |
||||||||
Upstream |
2,198 |
11,542 |
1,726 |
2,478 |
5,770 |
||||||||
Downstream |
1,718 |
2,703 |
2,889 |
2,282 |
4,410 |
||||||||
Oil Products |
1,717 |
1,892 |
2,880 |
2,279 |
4,360 |
||||||||
Chemicals |
1 |
811 |
9 |
3 |
50 |
||||||||
Corporate |
62 |
18 |
17 |
511 |
20 |
Divestments is a non-GAAP measure used to monitor the progress of Shell’s divestment programme. This measure comprises proceeds from sale of property, plant and equipment and businesses, joint ventures and associates, and other Integrated Gas, Upstream and Downstream investments, adjusted on an accruals basis and for any share consideration received or contingent consideration initially recognised upon the related divestment, as well as proceeds from the sale of interests in entities while retaining control (for example, proceeds from sale of interests in Shell Midstream Partners, L.P.).
Capital employed [A] (at December 31) |
$ million |
||||||
---|---|---|---|---|---|---|---|
|
2018 |
2017 |
2016 |
2015 |
2014 |
||
|
|||||||
Integrated Gas |
86,850 |
87,462 |
86,631 |
62,481 |
62,127 |
||
Upstream |
115,312 |
119,253 |
128,782 |
84,727 |
88,692 |
||
Downstream |
56,633 |
56,431 |
52,672 |
46,280 |
48,925 |
||
Oil Products |
39,748 |
41,186 |
38,926 |
34,444 |
38,512 |
||
Chemicals |
16,885 |
15,245 |
13,746 |
11,836 |
10,413 |
||
Corporate |
20,563 |
20,331 |
12,903 |
29,012 |
18,582 |
||
Total |
279,358 |
283,477 |
280,988 |
222,500 |
218,326 |
Capital investment |
$ million |
||||
---|---|---|---|---|---|
|
2018 |
2017 |
2016 |
2015 |
2014 |
Capital expenditure |
|
|
|
|
|
Integrated Gas |
3,262 |
3,515 |
3,994 |
4,580 |
6,054 |
Upstream |
|
|
|
|
|
Europe |
1,326 |
1,376 |
2,198 |
2,729 |
3,420 |
Asia |
528 |
773 |
1,624 |
2,272 |
2,733 |
Oceania |
– |
– |
– |
– |
– |
Africa |
1,634 |
625 |
1,142 |
2,441 |
2,452 |
North America |
6,602 |
6,951 |
5,682 |
8,507 |
10,512 |
South America |
2,357 |
1,664 |
2,064 |
457 |
847 |
Total Upstream |
12,447 |
11,389 |
12,710 |
16,406 |
19,964 |
Downstream |
|
|
|
|
|
Oil Products |
3,943 |
3,472 |
3,322 |
3,231 |
3,718 |
Chemicals |
3,140 |
2,354 |
1,987 |
1,757 |
1,802 |
Total Downstream |
7,083 |
5,826 |
5,309 |
4,988 |
5,520 |
Corporate |
219 |
115 |
103 |
157 |
138 |
Total capital expenditure |
23,011 |
20,845 |
22,116 |
26,131 |
31,676 |
Capital investment related to the acquisition of BG Group plc |
– |
– |
52,904 |
– |
– |
Investments in joint ventures and associates |
880 |
595 |
1,330 |
896 |
1,426 |
Exploration expense |
889 |
1,048 |
1,274 |
2,948 |
2,244 |
Finance leases |
452 |
1,074 |
2,343 |
91 |
2,124 |
Other |
(453) |
444 |
(90) |
(1,205) |
(131) |
Capital investment |
24,779 |
24,006 |
79,877 |
28,861 |
37,339 |
Comprising: |
|
|
|
|
|
Integrated Gas |
4,460 |
3,827 |
26,214 |
5,178 |
9,124 |
Upstream |
12,525 |
13,648 |
47,507 |
18,349 |
22,169 |
Downstream |
7,564 |
6,416 |
6,057 |
5,119 |
5,910 |
Oil Products |
4,351 |
3,952 |
3,595 |
3,352 |
4,091 |
Chemicals |
3,213 |
2,464 |
2,462 |
1,767 |
1,819 |
Corporate |
230 |
115 |
99 |
215 |
136 |
Total |
24,779 |
24,006 |
79,877 |
28,861 |
37,339 |
Of which |
|
|
|
|
|
Organic capital investment |
24,295 |
22,177 |
26,913 |
28,403 |
34,082 |
Inorganic capital investment |
484 |
1,829 |
52,964 |
458 |
3,257 |
Capital investment is a non-GAAP measure used to make decisions about allocating resources and assessing performance. It comprises capital expenditure, exploration expense excluding well write-offs, new investments in joint ventures and associates, new finance leases and investments in Integrated Gas, Upstream and Downstream securities, all of which are on an accruals basis. In 2016, it also included the capital investment related to the acquisition of BG Group plc. The reconciliation of capital investment to capital expenditure is provided above.
Organic capital investment includes capital expenditure and new finance leases of existing subsidiaries, investments in existing joint ventures and associates, and exploration expense (excluding well write-offs). Inorganic capital investment includes investments related to the acquisition of businesses, investments in new joint ventures and associates, and new acreage.